methotrexate has been researched along with Colitis Gravis in 145 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (6.90) | 18.7374 |
1990's | 18 (12.41) | 18.2507 |
2000's | 31 (21.38) | 29.6817 |
2010's | 71 (48.97) | 24.3611 |
2020's | 15 (10.34) | 2.80 |
Authors | Studies |
---|---|
Benkov, KJ; Colletti, RB; Crandall, W; Dotson, JL; Hunter, T; Komocsar, WJ; Liu, C; Steiner, SJ; Zhang, N | 1 |
Berger, T; Broekaert, IJ; Foeldvari, I; Geikowski, T; Horneff, G; Hospach, A; Hufnagel, M; Klein, A; Küster, M; Minden, K; Oommen, P; Quietzsch, J; Rogalski, B; Weller-Heinemann, F; Windschall, D | 1 |
Haq, SA; Momen Majumder, MS; Rasker, JJ | 1 |
Temtem, TA; Vickers, M; Whitworth, J | 1 |
Chhibba, T; Ma, C | 1 |
Bavaharan, B; Kawali, A; Mahendradas, P; Mohan, A; Sanjay, S; Shetty, B | 1 |
Chevreau, J; Foulon, A; Fumery, M; Gondry, J; Yzet, C | 1 |
Gurney, ME; Kaelber, DC; Xu, R; Zhou, M | 1 |
Benchimol, EI; Bernstein, CN; Coward, S; Jones, J; Kaplan, GG; Kuenzig, ME; Murthy, SK; Nguyen, GC; Peña-Sánchez, JN; Singh, H; Targownik, LE; Tennakoon, A; Zubieta, AA | 1 |
Cordeiro, G; Dias, AM; Estevinho, MM; Magro, F | 1 |
Ahuja, V; Andoh, A; Chen, M; Han, DS; Hibi, T; Hilmi, IN; Hu, PJ; Jeen, YT; Kim, HJ; Leung, WK; Matsuoka, K; Ng, SC; Ooi, CJ; Qian, J; Ran, Z; Sollano, J; Suzuki, Y; Watanabe, M; Wei, SC; Wu, K; Yang, SK | 1 |
Heron, V; Loftus, EV | 1 |
Anikhindi, SA; Arora, A; Bansal, N; Gupta, P; Kumar, A; Sharma, P; Singla, V; Walinjkar, S | 1 |
Arai, D; Asakura, T; Betsuyaku, T; Ishii, M; Sugiura, H; Takei, H; Takeuchi, T | 1 |
Gouynou, C; Peyrin-Biroulet, L | 1 |
Dudler, J; Fournier, N; Michetti, P; Pittet, V; Rouiller-Braunschweig, C | 1 |
Jiang, X; Liao, W; Long, S; Lu, N; Shu, X; Zhu, X; Zhu, Z | 1 |
Long, MD; Vanga, R | 1 |
Bouma, G; de Boer, NKH; Dijkstra, G; Hoentjen, F; Meijer, B; Mulder, CJJ; Oldenburg, B; Ponsioen, CY; van Bodegraven, AA; van der Meulen, AE; van der Woude, CJ; Wintjens, DSJ | 1 |
Abraham, B; Anton, K; Barnes, EL; Cross, RK; Dryden, G; Fischer, M; Hanson, J; Harlan, W; Herfarth, H; Higgins, PDR; Isaacs, KL; Ivanova, A; Jackson, S; Levy, C; Lewis, JD; Long, MD; Martin, C; McCabe, R; Osterman, MT; Polyak, S; Saha, S; Sandler, RS; Sands, BE; Serrano, J; Valentine, JF; Williams, E; Yajnik, V | 1 |
Church, PC; de Ridder, L; Griffiths, AM; Hyams, J; Ruemmele, F; Turner, D | 1 |
Hanauer, SB; Lichtenstein, GR; Sandborn, WJ | 1 |
Dulai, PS | 1 |
Burns, C; Yetto, T | 1 |
Aviña, A; Benchimol, EI; Bernstein, CN; Coward, S; Jones, J; Kaplan, G; Leung, S; Lix, L; Murthy, SK; Nguyen, GC; Peña-Sánchez, JN; Singh, H; Targownik, LE; Tennakoon, A | 1 |
Cohen, S; Galai, T; Moran-Lev, H; Yerushalmy-Feler, A | 1 |
Ainsworth, MA; Nielsen, OH; Steenholdt, C | 1 |
de Boer, NKH; Dijkstra, G; Hoentjen, F; Lissenberg-Witte, BI; Oldenburg, B; Pierik, M; Ponsioen, CY; Simsek, M; van der Meulen, AE; van der Woude, CJ; van Riswijk, MLM; Verschuren, S | 1 |
Bjerrum, JT; Herfarth, H; Nielsen, OH; Rogler, G | 1 |
Kane, SV; Yarur, A | 1 |
Abbas, AM; Balart, L; Khan, N; Moehlen, M | 1 |
Kiss, LS; Lakatos, PL; Mandel, M; Miheller, P | 1 |
Adedokun, OJ; Collins, J; Colombel, JF; Feagan, BG; Gibson, PR; Guzzo, C; Hibi, T; Järnerot, G; Johanns, J; Marano, C; Reinisch, W; Rutgeerts, P; Sandborn, WJ; Strauss, R; Zhang, H | 1 |
Adedokun, OJ; Collins, J; Colombel, JF; Feagan, BG; Gibson, PR; Guzzo, C; Järnerot, G; Johanns, J; Marano, C; Reinisch, W; Rutgeerts, P; Sandborn, WJ; Strauss, R; Zhang, H | 1 |
Lago, P; Magalhães, RK; Pedroto, I | 1 |
Mudter, J; Neurath, MF | 1 |
Arakawa, T; Fujiwara, Y; Fukushima, W; Hagihara, Y; Hirota, Y; Kamata, N; Maeda, K; Ohfuji, S; Shiba, M; Sogawa, M; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamagami, H | 1 |
Dubinsky, MC; Rabizadeh, S; Vahabnezhad, E | 1 |
Chande, N; MacDonald, JK; McDonald, JW; Wang, Y | 1 |
Sicilia, B | 1 |
Charro, M; Domènech, E; García-López, S; Gisbert, JP; Gomollón, F; Muñoz, F; Rubio, S | 1 |
Alves, VB; Basso, PJ; Bonfá, G; Cardoso, CR; Fonseca, MT; Nardini, V; Sales-Campos, H | 1 |
Ben-Horin, S; Bossuyt, P; Bouguen, G; Dotan, I; Jussila, A; Karmiris, K; Katsanos, KH; Kruis, W; Legido, J; Li, AC; Moreels, T; Naismith, GD; Preiss, JC; Scarcelli, A; Sorrentino, D; Steinwurz, F; Subramaniam, K; Tarabar, D; Yanai, H; Zaganas, IV | 1 |
Büning, J; Fellermann, K; Lehnert, H; Mackenroth, T; Möller, S; Olsen, V; Schmidt, KJ; Schröder, T; Sina, C | 1 |
El-Matary, W; Griffiths, AM; MacDonald, JK; Vandermeer, B; Wang, Y | 1 |
Ballet, V; Bollen, L; Ferrante, M; Gils, A; van Assche, G; Vande Casteele, N; Vermeire, S | 1 |
Chande, N; Feagan, BG; Marshall, JK; Nelson, S; Parker, CE; Sandborn, WJ; Seow, CH | 1 |
Abitbol, V; Allez, M; Bommelaer, G; Bossa, F; Bouhnik, Y; Bourreille, A; Brixi, H; Carbonnel, F; Colombel, JF; Coulibaly, B; Danese, S; Deplanque, D; Dewit, O; Färkkilä, M; Filippi, J; Fumery, M; Katsanos, KH; Laharie, D; Louis, E; Malamut, G; Michetti, P; Moreau, J; Nachury, M; Novacek, G; Peyrin-Biroulet, L; Reinisch, W; Roblin, X; Sarter, H; Seksik, P | 1 |
Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
Herfarth, HH | 1 |
Afzali, A; Hu, JK; Lee, SD; Park, CJ; Sharma, P; Sinanan, MN; Zhu, K | 1 |
Ott, C | 1 |
Cottone, M; Macaluso, FS; Orlando, A; Renna, S | 1 |
Fernández-Bañares, F; Gisbert, JP | 1 |
Kobashigawa, T; Kotake, S; Nanke, Y; Yamanaka, H | 1 |
Grossman, AB; Maxwell, EC | 1 |
Annese, V; Deiana, S; Gabbani, T; Lunardi, S; Manetti, N | 1 |
Charpentier, C; Cheddani, H; Dauchet, L; Dupas, JL; Fumery, M; Gower-Rousseau, C; Marie Bouvier, A; Pariente, B; Peyrin-Biroulet, L; Savoye, G | 1 |
Achkar, JP; Brzezinski, A; Garber, A; Horton, N; Lashner, BA; Philpott, J; Shen, B; Wu, X | 1 |
Bar-Gil Shitrit, A; Ben-Horin, S; Chowers, Y; Eliakim, R; Engel, T; Fudim, E; Kopylov, U; Lang, A; Paul, S; Picard, O; Roblin, X; Ungar, B; Williet, N; Yavzori, M | 1 |
Cui, DJ; Hu, M; Yang, LC; Yang, XL | 1 |
Aicart, M; Alcaín, G; Almela, P; Arguelles-Arias, F; Arias-Rivera, ML; Barreiro-de Acosta, M; Barrio, J; Beltrán, B; Benítez, JM; Bermejo, F; Botella, B; Bujanda, L; Busquets, D; Calvet, X; Casanova, MJ; Castaño-Milla, C; Castro, E; Castro, L; Ceballos, D; Chaparro, M; Cortés, X; Domènech, E; Domínguez, M; Domínguez-Antonaya, M; Dueñas, C; Esteve, M; Fernández-Salazar, L; García-Herola, A; García-López, S; García-Planella, E; García-Sánchez, V; García-Sepulcre, MF; Garrido, E; Gisbert, JP; Gómez-García, M; Gomollón, F; González-Lama, Y; Guardiola, J; Gutiérrez, A; Hernández-Martínez, A; Hervías, D; Hinojosa, J; Huguet, JM; Jauregui-Amezaga, A; Khorrami, S; Leo, E; Llaó, J; Lorente-Poyatos, R; Mañosa, M; Marín-Jiménez, I; Marrero, JM; Martín-Arranz, M; Martinez-Montiel, MP; Menacho, M; Merino, O; Monfort, D; Moraleja, I; Muñoz, C; Muñoz, F; Nantes, O; Navarro-Llavat, M; Novella, MT; Opio, V; Pajares, R; Pérez-Calle, JL; Pérez-Martínez, I; Pineda, JR; Ponferrada, A; Ramírez-de la Piscina, P; Ramos, L; Robles-Alonso, V; Rodríguez, C; Rodríguez, GE; Rodríguez-Pérez, A; Rojas-Feria, M; Roncedo, O; Sánchez-Torres, A; Sicilia, B; Taxonera, C; Tosca, J; Van Domselaar, M; Vázquez, JM; Vega-López, AB | 1 |
Agnholt, J | 1 |
Hutas, G | 1 |
Burakoff, R | 1 |
El-Matary, W; Griffiths, AM; Vandermeer, B | 1 |
Belaiche, J; Louis, E; Reenaers, C | 1 |
Herfarth, HH; Isaacs, KL; Lewis, JD; Osterman, MT; Sands, BE | 1 |
Bischoff, A | 1 |
Beaugerie, L; Carrat, F; Cosnes, J; Nion-Larmurier, I; Seksik, P; Sokol, H; Vienne, A | 1 |
Kane, S | 1 |
Aloi, M; Cavallari, N; Conte, F; Cucchiara, S; Di Nardo, G; Mazzeo, L; Nuti, F; Stronati, L | 1 |
de Francisco, R; Fernández-García, MS; García-Pravia, C; Gutiérrez-Corral, N; Riestra, S; Rodrigo, L; Rodríguez, JI; Rodríguez-Peláez, M | 1 |
Deslandres, C; Noble, A; Willot, S | 1 |
Ford, AC; Hamlin, PJ; Jackson, EL | 1 |
Dubinsky, MC; Ford, AC; Khan, KJ; Moayyedi, P; Talley, NJ; Ullman, TA | 1 |
Carbonnel, F | 1 |
Gudkova, RB; Khomeriki, SG; Kniazev, OV; Konopliannikov, AG; Konopliannikova, OA; Lazebnik, LB; Mikhaĭlova, ZF; Parfenov, AI; Rogozina, VA; Ruchkina, IN; Shcherbakov, PL; Tsaregorodtseva, TM | 1 |
Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C | 1 |
Aguas, M; Barreiro-de Acosta, M; Carpio, D; Castro, L; Chaparro, M; García, V; García-Bosch, O; Mañosa, M | 1 |
Bell, SJ; Brown, SJ; Chan, FK; Chan, H; Chow, DK; Connell, WR; De Cruz, P; Desmond, PV; Kamm, MA; Leong, RW; Lust, M; Ng, SC; Prideaux, L; Sung, JJ; Williams, J; Wu, JC | 1 |
Algaba, A; Barbero-Villares, A; Bermejo, F; Gisbert, JP; López-Sanromán, A; Maté, J; Mendoza Jiménez-Ridruejo, J; Mendoza, JL; Moreno-Otero, R; Pajares, R; Pérez-Calle, JL; Taxonera, C | 1 |
Kiss, SL; Lakatos, PL; Lorinczy, K; Miheller, P | 1 |
Limdi, JK; Muhammad, R; Wong, CL | 1 |
Boyle, B; Colletti, RB; Crandall, WV; Kappelman, MD; King, E; Lee, GJ; Pratt, JM | 1 |
Makol, A; Sokumbi, O; Warrington, KJ; Wetter, DA | 1 |
Kim, HS; Kim, YS; Lee, J | 1 |
Ammendola, A; Diculescu, M; Dietrich, B; Fellermann, K; Hartmann, H; Hentsch, B; Herrlinger, KR; Howaldt, S; Nikolov, R; Otte, JM; Petrov, A; Reindl, W; Stange, EF; Stoynov, S; Strauch, U; Sturm, A; Voiosu, R | 1 |
Herfarth, HH; Isaacs, KL; Long, MD | 1 |
Crispino, P; Iacopini, F; Iannoni, C; Marcheggiano, A; Paoluzi, OA; Paoluzi, P; Pica, R; Rivera, M | 1 |
Alstead, EM; Nelson-Piercy, C | 1 |
Göke, B; Ochsenkühn, T; Sackmann, M | 1 |
Folwaczny, C; Siveke, JT | 1 |
Fraser, AG | 1 |
Schröder, O; Stein, J | 2 |
GOLDGRABER, MB; KIRSNER, JB | 1 |
Hanioka, K; Maeda, A; Matsushita, A; Nagai, K; Sugimoto, N; Takahashi, T; Watanabe, N | 1 |
Ansari, A; Hirst, J; Raoof, S; Sanderson, JD; Soon, SY; Yaneza, M | 1 |
Iacopini, F; Paoluzi, OA; Paoluzi, P; Pica, R | 1 |
Dignass, AU; Herrlinger, K; Schölmerich, J | 1 |
Dejaco, C; Knoflach, P; Petritsch, W; Reinisch, W; Tilg, H; Vogelsang, H | 1 |
Stiefelhagen, P | 1 |
Herrlinger, K; Stange, EF | 1 |
Cummings, JR; Gorard, DA; Herrlinger, KR; Jewell, DP; McIntyre, AS; Travis, SP | 1 |
Ahmad, T; Barnardo, MC; Cummings, JR; Herrlinger, KR; Jewell, DP; Schwab, M | 1 |
Barta, Z; Tóth, L; Zeher, M | 1 |
Amezcua-Guerra, LM; Bojalil, R; Hernández-Martínez, B; Pineda, C | 1 |
Pierik, M; Rutgeerts, P; Vermeire, S; Vlietinck, R | 1 |
Gibson, PR; Iser, JH; Nathan, DM | 1 |
Chande, N; MacDonald, JK; McDonald, JW | 1 |
Chalumeau, S; Claudel-Bonvoisin, S; Flourié, B; Moussata, D; Nancey, S; Saurin, JC | 1 |
Atherton, LD; Kaye, MD; Leib, ES | 1 |
Korelitz, BI | 1 |
Driessen, WM; Houben, MH; van Spreeuwel, JP; van Wijk, HJ | 1 |
van Hogezand, RA | 1 |
Baratz, M; Gilat, T; Hallak, A; Halpern, Z; Rabau, M; Santo, M; Werbin, N | 1 |
Baron, TH; Elson, CO; Truss, CD | 1 |
Daum, F; Grancher, K; Mandel, F; Markowitz, J | 1 |
Chakravarty, BJ | 1 |
Arber, N; Bardan, E; Broide, E; Eliakim, R; Fich, A; Gilat, T; Keter, D; Lavy, A; Moshkowitz, M; Odes, S; Oren, R; Patz, J; Pomeranz, I; Reisfeld, I; Ron, Y; Villa, Y | 1 |
Kozarek, RA | 1 |
Lichtenstein, GR; Stotland, BR | 1 |
Schölmerich, J | 1 |
Modigliani, R | 1 |
Baert, F; Rutgeerts, P | 1 |
Hanauer, SB; Stein, RB | 1 |
Kougo, Y | 1 |
Egan, LJ; Leighton, JA; Lipsky, JJ; Mays, DC; Pike, MG; Sandborn, WJ; Tremaine, WJ; Zinsmeister, AR | 1 |
Faubion, WA; Sandborn, WJ | 1 |
Baker, AL; Conjeevaram, HS; Hanauer, SB; Kuan, SF; Schiano, TD; Te, HS | 1 |
Egan, LJ; Lipsky, JJ; Mays, DC; Sandborn, WJ; Tremaine, WJ | 1 |
DiPiro, JT; Vandell, AG | 1 |
Cerný, K; Krajcí, A; Uvízi, J | 1 |
Kessinger, A; Novak, RA | 1 |
Belaiche, J; Delwaide, J; Gast, P; Louis, E | 1 |
Ball, TJ; Botoman, VA; Gelfand, MD; Kozarek, RA; Patterson, DJ; Wilske, KR | 1 |
Schwartz, RS; Swanson, MA | 1 |
Scheiffarth, F; Warnatz, H | 1 |
Moeschlin, S | 1 |
Schwartz, RS; Skinner, MD | 1 |
46 review(s) available for methotrexate and Colitis Gravis
Article | Year |
---|---|
Is there room for immunomodulators in ulcerative colitis?
Topics: Clinical Trials as Topic; Colitis, Ulcerative; Gastrointestinal Diseases; Humans; Immunologic Factors; Methotrexate; Purines; Severity of Illness Index; Treatment Outcome | 2020 |
[IBD and pregnancy: From conception to birth].
Topics: Cesarean Section; Colitis, Ulcerative; Crohn Disease; Delivery, Obstetric; Female; Fertilization; Fetus; Gestational Age; Humans; Infant, Newborn; Infertility; Inflammatory Bowel Diseases; Male; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thalidomide | 2020 |
Inflammatory Bowel Disease - Non-biological treatment.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Digestive System Surgical Procedures; Gastrointestinal Agents; Humans; Mesalamine; Methotrexate; Tacrolimus; Treatment Outcome | 2020 |
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Asia; Azathioprine; Colitis, Ulcerative; Crohn Disease; Diagnosis, Differential; Female; Gastroenterology; Humans; Immunosuppressive Agents; Male; Methotrexate; Monitoring, Physiologic; Pacific Islands; Practice Guidelines as Topic; Pregnancy; Remission Induction; Societies, Medical; Tuberculosis, Gastrointestinal | 2021 |
Nonbiologic Immune Suppression in Ulcerative Colitis.
Topics: Azathioprine; Colitis, Ulcerative; Contraindications, Drug; Glucocorticoids; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Meta-Analysis as Topic; Methotrexate; Piperidines; Pyrimidines; Remission Induction | 2020 |
Contemporary Management of Ulcerative Colitis.
Topics: Azathioprine; Colectomy; Colitis, Ulcerative; Drug Monitoring; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Infliximab; Methotrexate; Tumor Necrosis Factor-alpha | 2018 |
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Topics: Anti-Inflammatory Agents; Azathioprine; Biological Products; Clinical Decision-Making; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Mercaptopurine; Methotrexate; Purines; Risk Factors; Thioguanine; Treatment Outcome | 2019 |
Recent advances using immunomodulators for inflammatory bowel disease.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate | 2013 |
Update on pregnancy and breastfeeding in the era of biologics.
Topics: Adalimumab; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Breast Feeding; Certolizumab Pegol; Colitis, Ulcerative; Contraindications; Crohn Disease; Cyclosporine; Female; Fertility; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Natalizumab; Polyethylene Glycols; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Tacrolimus | 2013 |
Methotrexate: should we start using it in clinical practice?
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction | 2013 |
[Treatment of chronic inflammatory bowel disease based on evidence and according to stage: top down].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Biological Products; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Early Medical Intervention; Evidence-Based Medicine; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Treatment Outcome | 2013 |
Methotrexate for induction of remission in ulcerative colitis.
Topics: Administration, Oral; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Induction Chemotherapy; Mercaptopurine; Mesalamine; Methotrexate; Randomized Controlled Trials as Topic | 2014 |
Classical and recent advances in the treatment of inflammatory bowel diseases.
Topics: Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell- and Tissue-Based Therapy; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Microbiota; Probiotics; Purines; Quality of Life; Tumor Necrosis Factor-alpha | 2015 |
Methotrexate for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Mesalamine; Methotrexate; Sulfasalazine | 2015 |
New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
Topics: Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Congresses as Topic; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Maintenance Chemotherapy; Mesalamine; Methotrexate; Review Literature as Topic; Secondary Prevention | 2015 |
Methotrexate for Inflammatory Bowel Diseases - New Developments.
Topics: Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Methotrexate; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |
Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Odds Ratio; Postoperative Complications; Preoperative Period; Retrospective Studies; Sepsis; Tumor Necrosis Factor-alpha; Young Adult | 2016 |
Advances in Pediatric Inflammatory Bowel Disease.
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Enteral Nutrition; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Sulfasalazine; Tacrolimus | 2016 |
Safety profile of methotrexate in inflammatory bowel disease.
Topics: Colitis, Ulcerative; Crohn Disease; Drug Resistance; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction; Steroids | 2016 |
Methotrexate for maintenance of remission in ulcerative colitis.
Topics: Administration, Oral; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction | 2009 |
Efficacy of methotrexate in ulcerative colitis: failure or promise.
Topics: Colitis, Ulcerative; Female; Folic Acid Antagonists; Humans; Male; Methotrexate; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome | 2010 |
Preparing the patient for immunosuppressive therapy.
Topics: Algorithms; Colitis, Ulcerative; Counseling; Crohn Disease; Glucocorticoids; Humans; Immunization Schedule; Immunosuppressive Agents; Medical History Taking; Mercaptopurine; Methotrexate; Methyltransferases; Patient Selection; Tumor Necrosis Factor-alpha | 2010 |
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Injections, Intramuscular; Mercaptopurine; Methotrexate; Remission Induction; Secondary Prevention; Treatment Failure | 2011 |
Methotrexate: a drug of the future in ulcerative colitis?
Topics: Clinical Trials as Topic; Colitis, Ulcerative; Humans; Methotrexate; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Retrospective Studies | 2011 |
[Epidemiology, predictors and clinical aspects of loss of response to biological therapy].
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Crohn Disease; Drug Tolerance; Gastrointestinal Agents; Humans; Immunologic Factors; Immunotherapy; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Randomized Controlled Trials as Topic; Risk Factors; Treatment Failure; Tumor Necrosis Factor-alpha | 2012 |
Methotrexate: underused and ignored?
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Methotrexate; Patient Preference; Treatment Outcome | 2012 |
[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Crohn Disease; Cyclosporins; Diagnosis, Differential; Gastrointestinal Agents; Humans; Ileostomy; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Meta-Analysis as Topic; Methotrexate; Parenteral Nutrition; Prednisolone; Quality of Life; Time Factors; Ultrasonography | 2003 |
Methotrexate: first-line or second-line immunomodulator?
Topics: Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Liver Cirrhosis; Methotrexate | 2003 |
Low dose methotrexate in inflammatory bowel disease: current status and future directions.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
[Chronic inflammatory bowel diseases].
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Controlled Clinical Trials as Topic; Crohn Disease; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Metronidazole; Pouchitis; Remission Induction; Tacrolimus; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Pharmacogenetics in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Methyltransferases; Pharmacogenetics; Polymorphism, Genetic; Sulfasalazine; Treatment Outcome | 2006 |
Methotrexate for induction of remission in ulcerative colitis.
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Methotrexate; Remission Induction | 2007 |
Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; History, 20th Century; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications | 1995 |
Medical management of patients with difficult-to-treat inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole | 1994 |
Newer treatments for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena | 1996 |
Immunosuppressive treatment for refractory ulcerative colitis--where do we stand and where are we going?
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-10; Mercaptopurine; Methotrexate | 1997 |
Drug therapy for ulcerative colitis during pregnancy.
Topics: Adrenal Cortex Hormones; Antidiarrheals; Azathioprine; Breast Feeding; Colitis, Ulcerative; Cyclosporine; Female; Humans; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine | 1997 |
Medical therapy for inflammatory bowel disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Recurrence; Salicylates; Severity of Illness Index; Steroids | 1999 |
[Recent progress in therapy of inflammatory bowel diseases].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Humans; Immunoglobulins, Intravenous; Leukapheresis; Mesalamine; Methotrexate; Receptors, Glucocorticoid; Steroids | 1999 |
Clinical pharmacology of inflammatory bowel disease therapies.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Colitis, Ulcerative; Crohn Disease; Drug Resistance; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mesalamine; Methotrexate; Pharmacogenetics; Receptors, Glucocorticoid | 2000 |
Maintenance drugs for inflammatory bowel disease.
Topics: Aminosalicylic Acids; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Infliximab; Methotrexate; Treatment Outcome | 2001 |
Low-dosage methotrexate for treatment and maintenance of remission in patients with inflammatory bowel disease.
Topics: Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Secondary Prevention | 2002 |
[Therapeutic alternatives in Crohn disease and in ulcero-hemorrhagic rectocolitis: current findings].
Topics: Antineoplastic Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Methotrexate | 1992 |
Cytotoxic drugs in treatment of nonmalignant diseases.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Granulomatosis with Polyangiitis; Hepatitis; Humans; Immune Complex Diseases; Immunosuppressive Agents; Infections; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Nephrotic Syndrome; Ophthalmia, Sympathetic; Psoriasis; Thioguanine; Uveitis | 1972 |
[Long-term therapy of immunologic diseases with special reference to the use of immunosuppressive agents].
Topics: Adrenocorticotropic Hormone; Alkylating Agents; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antimetabolites; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Colitis, Ulcerative; Cyclophosphamide; Humans; Immunosuppressive Agents; Liver Cirrhosis; Lupus Erythematosus, Systemic; Methotrexate; Nephritis; Thrombocytopenia; Time Factors | 1969 |
Immunosuppressive therapy. 1.
Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid; Azathioprine; Blood Coagulation Disorders; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Dermatomyositis; Factor VIII; Hepatitis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Prednisolone; Purpura, Thrombocytopenic; Scleroderma, Systemic | 1972 |
14 trial(s) available for methotrexate and Colitis Gravis
Article | Year |
---|---|
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Steroids; Time Factors; Treatment Outcome; United States | 2018 |
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Mercaptopurine; Methotrexate; Middle Aged; Quality of Life; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Middle Aged; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Gastrointestinal Agents; Humans; Injections, Intramuscular; Injections, Subcutaneous; Male; Methotrexate; Middle Aged; Remission Induction; Time Factors; Treatment Outcome; Wound Healing | 2016 |
[Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation].
Topics: Adult; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Stromal Cells; Transplantation, Homologous | 2010 |
Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Biphenyl Compounds; Blood Sedimentation; C-Reactive Protein; Colitis, Ulcerative; Crohn Disease; Dicarboxylic Acids; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Feces; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Intention to Treat Analysis; Leukocyte L1 Antigen Complex; Male; Methotrexate; Middle Aged; Oxidoreductases Acting on CH-CH Group Donors; Prednisolone; Remission Induction; Severity of Illness Index; Young Adult | 2013 |
Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Single-Blind Method; Treatment Outcome | 2002 |
Pulse cyclophosphamide therapy for inflammatory bowel disease.
Topics: Adult; Aged; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pilot Projects; Prospective Studies; Pulse Therapy, Drug; Remission Induction | 2006 |
[Methotrexate as possible treatment in refractory chronic inflammatory intestinal disease].
Topics: Adolescent; Adult; Colitis; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Female; Humans; Ileitis; Male; Methotrexate; Middle Aged; Treatment Outcome | 1994 |
Low-dose oral methotrexate in refractory inflammatory bowel disease.
Topics: Administration, Oral; Adult; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methotrexate; Pilot Projects; Prednisone; Time Factors; Treatment Outcome | 1993 |
Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Chronic Disease; Colitis, Ulcerative; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Israel; Male; Methotrexate; Middle Aged; Remission Induction | 1996 |
[Methotrexate in therapy of chronic inflammatory bowel diseases].
Topics: Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Intestinal Mucosa; Methotrexate; Prednisone; Prospective Studies | 1996 |
A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis.
Topics: Adult; Aged; Antirheumatic Agents; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Female; Humans; Inflammation; Male; Methotrexate; Middle Aged; Single-Blind Method; Time Factors; Treatment Outcome | 1999 |
Immunosuppressive therapy. 1.
Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid; Azathioprine; Blood Coagulation Disorders; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Dermatomyositis; Factor VIII; Hepatitis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Prednisolone; Purpura, Thrombocytopenic; Scleroderma, Systemic | 1972 |
86 other study(ies) available for methotrexate and Colitis Gravis
Article | Year |
---|---|
Treatment and biologic maintenance-dosing patterns among pediatric patients with ulcerative colitis or Crohn's disease.
Topics: Adalimumab; Biological Factors; Biological Products; Child; Colitis, Ulcerative; Crohn Disease; Humans; Infliximab; Methotrexate; Tumor Necrosis Factor Inhibitors | 2023 |
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Disease; Etanercept; Humans; Inflammatory Bowel Diseases; Leflunomide; Methotrexate; Retrospective Studies; Sulfasalazine | 2023 |
Tofacitinib for the treatment of inflammatory bowel disease-associated arthritis: two case reports.
Topics: Adult; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Female; Humans; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Sulfasalazine | 2023 |
Weekly Folic Acid Is a Convenient and Well-Tolerated Alternative to Daily Dosing in Pediatric Patients with Inflammatory Bowel Disease on Methotrexate.
Topics: Adolescent; Adult; Child; Child, Preschool; Colitis, Ulcerative; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Young Adult | 2023 |
A Long-Term Follow-up of Retinal Vasculitis - Do They Develop Systemic Disease?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retinal Vasculitis; Retrospective Studies; Tuberculin Test; Tuberculosis, Ocular; Visual Acuity; Vitreous Hemorrhage | 2020 |
Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.
Topics: Adalimumab; Adolescent; Adult; Aged; Alzheimer Disease; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Case-Control Studies; Colitis, Ulcerative; Etanercept; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk; Tumor Necrosis Factor Inhibitors; Young Adult | 2020 |
Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.
Topics: Adult; Ambulatory Care; Biological Products; Clinical Decision-Making; Colitis, Ulcerative; Decision Support Techniques; Drug Therapy, Combination; Humans; Immunologic Factors; Methotrexate; Piperidines; Practice Guidelines as Topic; Pyrimidines; Pyrroles; Severity of Illness Index | 2020 |
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications.
Topics: Adalimumab; Adult; Azathioprine; Biological Products; Canada; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Infliximab; Male; Methotrexate; Outcome and Process Assessment, Health Care; Patient Selection; Practice Patterns, Physicians'; Treatment Failure; Tumor Necrosis Factor Inhibitors | 2020 |
Multifocal colorectal non-Hodgkin's lymphoma in a patient with ulcerative colitis: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Biopsy; Colitis, Ulcerative; Colonoscopy; Colorectal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2021 |
Pulmonary Cryptococcosis Developed from a Nodule after Treatment with Infliximab for Arthritis Associated with Ulcerative Colitis.
Topics: Aged; Antifungal Agents; Arthritis; Colitis, Ulcerative; Cryptococcosis; Humans; Immunocompromised Host; Infliximab; Lung; Lung Diseases, Fungal; Male; Methotrexate; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha | 2017 |
Letter: addition of methotrexate neither restores clinical response nor improves the pharmacokinetic profile of vedolizumab-treated patients.
Topics: Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Humans; Methotrexate | 2017 |
Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Intestinal Mucosa; Longitudinal Studies; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Wound Healing; Young Adult | 2017 |
Ulcerative colitis followed by the development of typical intestinal Behçet disease: A case report.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Behcet Syndrome; Colitis, Ulcerative; Colonoscopy; Gastrointestinal Tract; Glucocorticoids; Humans; Male; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome | 2018 |
Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness.
Topics: Adult; Colitis, Ulcerative; Databases, Factual; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Netherlands; Proportional Hazards Models; Prospective Studies; Remission Induction; Thioguanine; Treatment Outcome | 2018 |
The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World.
Topics: Adalimumab; Adolescent; Africa; Asia; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Europe; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Infliximab; Internationality; Methotrexate; North America; Oceania; Practice Patterns, Physicians'; South America; Surveys and Questionnaires; Tumor Necrosis Factor-alpha | 2018 |
Methotrexate Monotherapy for Induction and Maintenance of Clinical Remission in Ulcerative Colitis: Dead on Arrival.
Topics: Colitis, Ulcerative; Humans; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction | 2018 |
Linear IgA bullous dermatosis associated with ulcerative proctitis: treatment challenge.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Linear IgA Bullous Dermatosis; Male; Mesalamine; Methotrexate; Methylprednisolone; Middle Aged; Proctitis; Retreatment | 2018 |
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
Topics: Adalimumab; Adult; Azathioprine; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Digestive System Surgical Procedures; Drug Substitution; Drug Therapy, Combination; Female; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Male; Manitoba; Methotrexate; Prednisone; Proportional Hazards Models; Retrospective Studies; Tumor Necrosis Factor Inhibitors | 2019 |
Predictors for Complicated Disease Course after Stepping Down from Combination to Antitumor Necrosis Factor Alpha Monotherapy in Children with Inflammatory Bowel Disease.
Topics: Adalimumab; Adolescent; Child; Colitis, Ulcerative; Crohn Disease; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Purines; Retrospective Studies; Risk Factors; Treatment Outcome; Tumor Necrosis Factor Inhibitors | 2020 |
Methotrexate for inflammatory bowel disease: time for reconsideration.
Topics: Anti-Inflammatory Agents; Biological Products; Clinical Decision-Making; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Evidence-Based Medicine; Gastrointestinal Agents; Humans; Methotrexate; Patient Selection; Remission Induction; Treatment Outcome | 2019 |
Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis.
Topics: Adolescent; Adult; Allopurinol; Beclomethasone; Colitis, Ulcerative; Crohn Disease; Databases, Factual; Female; Humans; Male; Mercaptopurine; Methotrexate; Netherlands; Off-Label Use; Thioguanine; Young Adult | 2019 |
Methotrexate in ulcerative colitis: a nationwide retrospective cohort from the Veterans Affairs Health Care System.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Colitis, Ulcerative; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; United States; United States Department of Veterans Affairs; Veterans; Young Adult | 2013 |
Treatment of inflammatory bowel disease with methotrexate in clinical practice.
Topics: Adult; Aged; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Patient Safety; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2013 |
Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Viral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunity, Active; Immunosuppressive Agents; Infliximab; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Male; Mercaptopurine; Methotrexate; Middle Aged; Prospective Studies; Tacrolimus | 2014 |
A 10-year, single tertiary care center experience on the durability of infliximab in pediatric inflammatory bowel disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Antibodies, Monoclonal; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Male; Methotrexate; Remission Induction; Retrospective Studies; Tertiary Care Centers; Time Factors; Treatment Failure; Young Adult | 2014 |
[No best treatment for severe outbreaks: Maintenance, the key in colitis].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Disease Management; Disease Progression; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Patient Preference; Practice Patterns, Physicians'; Salicylates; Tumor Necrosis Factor-alpha | 2011 |
[Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
Topics: Adult; Antiemetics; Antirheumatic Agents; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Child; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Nausea; Ondansetron | 2015 |
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cerebrovascular Disorders; Certolizumab Pegol; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Rare Diseases; Retreatment; Retrospective Studies; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment.
Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Body Mass Index; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Fatty Liver; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Ultrasonography; Young Adult | 2015 |
Thromboembolism as an important complication of inflammatory bowel disease.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Pulmonary Embolism; Recurrence; Retrospective Studies; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis | 2016 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
[News on the impact of Methotrexate as therapeutic option in patients with ulcerative colitis].
Topics: Colitis, Ulcerative; Humans; Immunosuppressive Agents; Methotrexate | 2016 |
The METEOR Trial: The Burial of Methotrexate in Ulcerative Colitis?
Topics: Colitis, Ulcerative; Humans; Immunosuppressive Agents; Methotrexate | 2016 |
Letter: oral low-dose methotrexate for collagenous colitis - authors' reply.
Topics: Colitis, Collagenous; Colitis, Ulcerative; Humans; Methotrexate | 2016 |
A case of enteropathic arthritis successfully treated with methotrexate.
Topics: Adult; Arthritis; Colitis, Ulcerative; Humans; Male; Methotrexate; Treatment Outcome | 2016 |
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Topics: Adrenal Cortex Hormones; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Carcinoma; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Female; Follow-Up Studies; France; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Intestinal Neoplasms; Lymphoproliferative Disorders; Male; Mesalamine; Methotrexate; Middle Aged; Myeloproliferative Disorders; Neoplasms; Proportional Hazards Models; Protective Factors; Registries; Retrospective Studies; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Child; Cohort Studies; Colectomy; Colitis, Ulcerative; Colonic Pouches; Crohn Disease; Digestive System Surgical Procedures; Enterostomy; Female; Hospitalization; Humans; Immunoglobulin G; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mesalamine; Methotrexate; Proctocolectomy, Restorative; Prognosis; Retrospective Studies; Young Adult | 2016 |
Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies; Antibody Formation; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunologic Factors; Male; Mercaptopurine; Methotrexate; Treatment Outcome; Young Adult | 2017 |
Effects of Preoperative Methotrexate on Complications After Surgery for Inflammatory Bowel Disease.
Topics: Colitis, Ulcerative; Humans; Inflammatory Bowel Diseases; Methotrexate | 2017 |
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
Topics: Adalimumab; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Colitis, Ulcerative; Colon; Constriction, Pathologic; Crohn Disease; Deprescriptions; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Ileum; Immunologic Factors; Incidence; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Risk Factors; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
[Biological therapy as treatment of inflammatory bowel diseases].
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunologic Factors; Immunosuppressive Agents; Infliximab; Methotrexate; Treatment Outcome | 2008 |
Golimumab, a fully human monoclonal antibody against TNFalpha.
Topics: Adult; Animals; Antibodies, Monoclonal; Arthritis, Rheumatoid; Asthma; Clinical Trials as Topic; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2008 |
Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome | 2008 |
Should patients under long-term anti-TNF therapies be followed for tuberculosis contamination?
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Corticosterone; Crohn Disease; Female; Gastrointestinal Agents; Humans; Infliximab; Latent Tuberculosis; Male; Methotrexate; Radiography; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2010 |
[Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Practice Guidelines as Topic; Prednisolone; Remission Induction | 2010 |
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Methotrexate; Prospective Studies; Registries; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
Methotrexate in paediatric ulcerative colitis: a retrospective survey at a single tertiary referral centre.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Child; Colitis, Ulcerative; Female; Humans; Longitudinal Studies; Male; Methotrexate; Remission Induction; Retrospective Studies | 2010 |
Kaposi's sarcoma: an opportunistic infection by human herpesvirus-8 in ulcerative colitis.
Topics: Aged; Colitis, Ulcerative; Colonic Neoplasms; Herpesvirus 8, Human; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Opportunistic Infections; Prednisone; Sarcoma, Kaposi | 2010 |
Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
Topics: Adolescent; Canada; Child; Child, Preschool; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Male; Maximum Tolerated Dose; Methotrexate; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome | 2011 |
VSL#3 and remission in active ulcerative colitis: larger studies required.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Bifidobacterium; Colitis, Ulcerative; Diet; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lactobacillus; Mesalamine; Methotrexate; Probiotics; Randomized Controlled Trials as Topic; Remission Induction; Reproducibility of Results; Severity of Illness Index | 2011 |
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus | 2011 |
Methotrexate in ulcerative colitis: a Spanish multicentric study on clinical use and efficacy.
Topics: Adult; Aged; Aged, 80 and over; Colitis, Ulcerative; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Retrospective Studies; Spain; Treatment Outcome | 2011 |
Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne.
Topics: Adolescent; Adult; Age Factors; Anal Canal; Analysis of Variance; Chi-Square Distribution; Colectomy; Colitis, Ulcerative; Constriction, Pathologic; Crohn Disease; Cyclosporine; Female; Hong Kong; Hospitalization; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Proportional Hazards Models; Sex Factors; Smoking; Steroids; Tumor Necrosis Factor Inhibitors; Victoria; Young Adult | 2012 |
Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Elasticity Imaging Techniques; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis; Logistic Models; Male; Methotrexate; Middle Aged | 2012 |
Vaccinating patients with inflammatory bowel disease--primum non nocere.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Crohn Disease; Female; Guideline Adherence; Humans; Immunosuppressive Agents; Infliximab; Male; Mass Screening; Methotrexate; Middle Aged; Practice Guidelines as Topic; Prednisolone; Vaccination | 2012 |
Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Body Height; Body Mass Index; Child; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Female; Growth; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Severity of Illness Index; Sex Factors; Treatment Outcome | 2012 |
Vasculitis associated with tumor necrosis factor-α inhibitors.
Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Etanercept; Female; Glucocorticoids; Hematuria; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Polyneuropathies; Prednisone; Proteinuria; Receptors, Tumor Necrosis Factor; Retrospective Studies; Rituximab; Tumor Necrosis Factor-alpha; Vasculitis; Young Adult | 2012 |
Sternocostal involvement in chronic recurrent multifocal osteomyelitis associated with ulcerative colitis.
Topics: Adult; Bone Density Conservation Agents; Colitis, Ulcerative; Diphosphonates; Drug Therapy, Combination; Humans; Male; Methotrexate; Osteomyelitis; Pamidronate; Recurrence; Treatment Outcome | 2013 |
Inflammatory bowel disease in pregnancy.
Topics: Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Infertility, Female; Infertility, Male; Inflammatory Bowel Diseases; Male; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Steroids; Sulfasalazine | 2003 |
Methotrexate in ulcerative colitis.
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Methotrexate | 2003 |
Inducing remission in inflammatory bowel disease.
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Remission Induction | 2003 |
CARCINOMA OF THE COLON IN ULCERATIVE COLITIS.
Topics: Aged; Aging; Cell Biology; Colitis; Colitis, Ulcerative; Colonic Neoplasms; Fluorouracil; Humans; Mechlorethamine; Methotrexate; Neoplasms; Pathology; Polyps; Radiography; Surgical Procedures, Operative | 1964 |
Association of intestinal malignant lymphoma and ulcerative colitis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Colonoscopy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphoma; Methotrexate; Peripheral Blood Stem Cell Transplantation; Sigmoid Neoplasms; Vincristine | 2003 |
Experience with the use of low-dose methotrexate for inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome | 2004 |
Low-dose methotrexate in ulcerative colitis: still a matter of debate.
Topics: Colitis, Ulcerative; Drug Administration Schedule; Humans; Immunosuppressive Agents; Methotrexate | 2004 |
[Ulcerative colitis. Chronic active course].
Topics: Administration, Oral; Adult; Age Factors; Anti-Infective Agents; Azathioprine; Child; Chronic Disease; Ciprofloxacin; Colectomy; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Diabetes Mellitus; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena; Pregnancy; Recurrence; Remission Induction; Risk Factors; Time Factors | 2004 |
[Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD].
Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Injections, Intramuscular; Male; Mercaptopurine; Methotrexate; Placebos; Pregnancy; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Time Factors | 2004 |
[Immunosuppressed patient becomes pregnant. Termination of pregnancy unavoidable?].
Topics: Abortion, Eugenic; Colitis, Ulcerative; Contraindications; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infant, Newborn; Methotrexate; Pregnancy; Pregnancy Complications; Risk Factors | 2004 |
Oral methotrexate in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome | 2005 |
The pharmacogenetics of methotrexate in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Case-Control Studies; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; DNA; Female; gamma-Glutamyl Hydrolase; Genetic Predisposition to Disease; Genotype; Humans; Male; Maximum Tolerated Dose; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Reduced Folate Carrier Protein; Transcription Factors; Treatment Outcome | 2005 |
Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis.
Topics: Abatacept; Antirheumatic Agents; Arthritis, Rheumatoid; Colitis, Ulcerative; Drug Therapy, Combination; Humans; Immunoconjugates; Male; Methotrexate; Middle Aged | 2006 |
A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
Topics: Adult; Aged; Aged, 80 and over; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Medical Records; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome | 2008 |
[Pancytopenia induced by two low-dose injections of methotrexate in a patient treated for ulcerative colitis].
Topics: Aged; Colitis, Ulcerative; Folic Acid Antagonists; Humans; Hypoalbuminemia; Immunosuppressive Agents; Injections, Subcutaneous; Klebsiella Infections; Klebsiella pneumoniae; Male; Methotrexate; Pancytopenia; Proctocolitis; Renal Insufficiency; Risk Factors; Sepsis | 2007 |
Toxic megacolon associated with methotrexate therapy.
Topics: Colitis, Ulcerative; Colon; Female; Humans; Megacolon, Toxic; Methotrexate; Middle Aged; Psoriasis | 1984 |
Ileitis after colectomy for ulcerative colitis or carcinoma.
Topics: Adult; Aged; Aminosalicylic Acids; Azathioprine; Colectomy; Colitis, Ulcerative; Colonic Neoplasms; Female; Humans; Ileitis; Ileum; Male; Mesalamine; Methotrexate; Middle Aged; Postoperative Complications | 1994 |
Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Topics: Adolescent; Adult; Attitude of Health Personnel; Azathioprine; Child; Colitis; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Gastroenterology; Health Surveys; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Pediatrics; Remission Induction; Retrospective Studies; Societies, Medical; Surveys and Questionnaires | 1993 |
Predictors and the rate of medical treatment failure in ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Cyclosporine; Discriminant Analysis; Female; Humans; Male; Mesalamine; Methotrexate; Prognosis; Risk Factors; Steroids; Treatment Failure | 1993 |
Methotrexate and ulcerative colitis: wrong drug? Wrong dose? Or wrong disease?
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Prednisone | 1996 |
Immunomodulator therapy of inflammatory bowel disease.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Blood Component Removal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytokines; Folic Acid Antagonists; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate | 1997 |
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
Topics: Adult; Biopsy; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Female; Folic Acid Antagonists; Humans; Liver; Male; Methotrexate; Time Factors | 2000 |
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease.
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Recurrence; Treatment Outcome | 2000 |
[Acute necrotizing colitis in a psoriatic treated by methotrexát (author's transl)].
Topics: Adult; Colitis, Ulcerative; Female; Humans; Methotrexate; Necrosis; Psoriasis | 1977 |
Methotrexate induced colitis.
Topics: Colitis, Ulcerative; Female; Humans; Methotrexate; Middle Aged; Radiography | 1976 |
Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease.
Topics: Colitis, Ulcerative; Colonoscopy; Crohn Disease; Humans; Methotrexate; Parenteral Nutrition, Total; Prednisone; Sigmoidoscopy | 1989 |
Immunosuppressive therapy. The relation between clinical response and immunologic competence.
Topics: Adolescent; Adult; Anemia, Hemolytic, Autoimmune; Antibody Formation; Azathioprine; Chronic Disease; Colitis, Ulcerative; Female; gamma-Globulins; Hemagglutination Tests; Hemocyanins; Humans; Hypersensitivity, Delayed; Isoantibodies; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Myositis; Nephrotic Syndrome; Purpura, Thrombocytopenic; Skin Tests | 1967 |
[Treatment of autoimmune diseases].
Topics: Adrenal Cortex Hormones; Aged; Anemia, Hemolytic, Autoimmune; Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Blood Protein Disorders; Child, Preschool; Chloramphenicol; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Drug Synergism; Female; Hepatitis; Humans; Immunosuppressive Agents; Long-Term Care; Lupus Vulgaris; Male; Methotrexate; Middle Aged; Nephrosis, Lipoid; Pemphigus; Polyarteritis Nodosa; Postoperative Complications; Purpura, Thrombocytopenic; Scleroderma, Systemic; Transplantation, Homologous | 1971 |